I understand the negativity but I for one acknowledge the immense effort undertaken by Patrys to progress the development of their antibody into this clinical trial.
True enough the announcement has done nothing for the SP but the fact that Onyx are prepared to investigate this combo is enough for me to leave my stash where it is. MM is a nasty disease and I wish the trial and its participants every success.
And of course, if they meet the trial objective s, we win big!
Ann: Patrys - Details of PAT-SM6 & Carfilzomib Clinical Trial, page-2
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1297395 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1116001 | 3 |
View Market Depth
| Last trade - 10.07am 29/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable